Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 27
1993 3
1994 7
1995 15
1996 28
1997 54
1998 44
1999 62
2000 75
2001 82
2002 73
2003 83
2004 78
2005 66
2006 56
2007 56
2008 52
2009 40
2010 38
2011 37
2012 30
2013 25
2014 30
2015 28
2016 35
2017 22
2018 20
2019 19
2020 21
2021 27
2022 22
2023 22
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,228 results

Results by year

Filters applied: . Clear all
Page 1
Quinupristin-Dalfopristin.
[No authors listed] [No authors listed] 2018 May 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2018 May 21. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643752 Free Books & Documents. Review.
Quinupristin and dalfopristin are intravenously administered, streptogramin antibiotics used in fixed combination to treat severe bacterial infections due to susceptible organisms including methicillin resistant Staphylococcus aureus (MRSA). The fixed combination of
Quinupristin and dalfopristin are intravenously administered, streptogramin antibiotics used in fixed combination to treat sev
Quinupristin-dalfopristin.
Bryson HM, Spencer CM. Bryson HM, et al. Drugs. 1996 Sep;52(3):406-15. doi: 10.2165/00003495-199652030-00006. Drugs. 1996. PMID: 8875130 Review.
Quinupristin-dalfopristin (RP 59500) is an injectable streptogramin antibiotic. ...Quinupristin-dalfopristin, by way synergism of between its 2 components, is unaffected by most forms of bacterial resistance. ...
Quinupristin-dalfopristin (RP 59500) is an injectable streptogramin antibiotic. ...Quinupristin-dalfopristin, by
Quinupristin-dalfopristin and linezolid: evidence and opinion.
Eliopoulos GM. Eliopoulos GM. Clin Infect Dis. 2003 Feb 15;36(4):473-81. doi: 10.1086/367662. Epub 2003 Jan 31. Clin Infect Dis. 2003. PMID: 12567306 Review.
Quinupristin-dalfopristin and linezolid demonstrate in vitro activity against a wide range of gram-positive bacteria, including many isolates resistant to earlier antimicrobials. Quinupristin-dalfopristin is inactive against Enterococcus faecalis but h
Quinupristin-dalfopristin and linezolid demonstrate in vitro activity against a wide range of gram-positive bacteria, includin
Quniupristin-Dalfopristin.
[No authors listed] [No authors listed] 2021 May 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 May 17. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000858 Free Books & Documents. Review.
Quinupristin and dalfopristin are relatively large molecules that are unlikely to be excreted into breastmilk in large amounts or to be absorbed orally by the breastfeeding infant.[1] However, since no information is available on the use of quinupristin and
Quinupristin and dalfopristin are relatively large molecules that are unlikely to be excreted into breastmilk in large amounts
Safety and tolerability of quinupristin/dalfopristin: administration guidelines.
Rubinstein E, Prokocimer P, Talbot GH. Rubinstein E, et al. J Antimicrob Chemother. 1999 Sep;44 Suppl A:37-46. doi: 10.1093/jac/44.suppl_1.37. J Antimicrob Chemother. 1999. PMID: 10511396 Review.
The safety and tolerability of quinupristin/dalfopristin were assessed in both comparative and non-comparative trials (2298 quinupristin/dalfopristin-treated patients). ...Results of laboratory tests while on therapy were comparable for quinupristin
The safety and tolerability of quinupristin/dalfopristin were assessed in both comparative and non-comparative trials (2298 …
Quinupristin-dalfopristin: an overview.
Delgado G Jr, Neuhauser MM, Bearden DT, Danziger LH. Delgado G Jr, et al. Pharmacotherapy. 2000 Dec;20(12):1469-85. doi: 10.1592/phco.20.19.1469.34858. Pharmacotherapy. 2000. PMID: 11130220 Review.
Both drugs are largely hepatically metabolized and excreted in bile. Although not metabolized by cytochrome P450 3A4, quinupristin-dalfopristin can inhibit agents that are metabolized through this pathway. ...Adverse events include arthralgia, myalgias, and infusion …
Both drugs are largely hepatically metabolized and excreted in bile. Although not metabolized by cytochrome P450 3A4, quinupristin- …
Quinupristin/dalfopristin.
Blondeau JM, Sanche SE. Blondeau JM, et al. Expert Opin Pharmacother. 2002 Sep;3(9):1341-64. doi: 10.1517/14656566.3.9.1341. Expert Opin Pharmacother. 2002. PMID: 12186626 Review.
The net result of these various resistance issues is a reduction in the number of appropriate antimicrobial agents for treating infected patients. Quinupristin/dalfopristin is a parental streptogramin with a spectrum of activity that includes Gram-positive pathogens …
The net result of these various resistance issues is a reduction in the number of appropriate antimicrobial agents for treating infected pat …
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
Shariati A, Dadashi M, Chegini Z, van Belkum A, Mirzaii M, Khoramrooz SS, Darban-Sarokhalil D. Shariati A, et al. Antimicrob Resist Infect Control. 2020 Apr 22;9(1):56. doi: 10.1186/s13756-020-00714-9. Antimicrob Resist Infect Control. 2020. PMID: 32321574 Free PMC article. Review.
Apparently, vancomycin is still an effective antibiotic for treatment of infections caused by these bacteria but in recent years, additional resistance phenotypes have led to the accelerated introduction of newer agents such as linezolid, tigecycline, daptomycin, and quinupris
Apparently, vancomycin is still an effective antibiotic for treatment of infections caused by these bacteria but in recent years, additional …
1,228 results